The kallikrein-kininogen-kinin system in chronic inflammation
Authors:
- 1 June 1989
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 27 (3-4) , 258-260
Abstract
We examined bradykinin's effects on macrophages and fibroblasts, two cell types important in the pathogenesis of chronic inflammation. Bradykinin stimulated release of proteins of 18 kDa from macrophages. These proteins caused increased thymocyte proliferation (interleukin 1, IL-1) and completely inhibited lipoprotein lipase (tumor necrosis factor, TNF). When fibroblasts were incubated with bradykinin, PGE2 synthesis was stimulated. Pretreatment with IL-1 or TNF dramatically amplified bradykinin-stimulated PGE2 synthesis. Thus, bradykinin is involved in a positive feedback loop in which bradykinin activates macrophages to release potent inflammatory cytokines; these in turn amplify responsiveness of bradykinin target tissues.Keywords
This publication has 5 references indexed in Scilit:
- Interleukin 1 amplifies receptor-mediated activation of phospholipase A2 in 3T3 fibroblasts.Proceedings of the National Academy of Sciences, 1988
- Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.Proceedings of the National Academy of Sciences, 1988
- Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells.The Journal of Immunology, 1985
- Pharmacology of bradykinin and related kinins.Pharmacological Reviews, 1980
- Partial Purification of Human Lymphocyte-Activating Factor (LAF) by Ultrafiltration and Electrophoretic TechniquesThe Journal of Immunology, 1977